Inhaltsverzeichnis
I. Physiology. - Vasoconstrictor Mechanisms and the Effects of Nitrates. - Functional and Metabolic Consequences of Chronic Alterations in Preload and Afterload in the Hypertrophied and Dilated Heart. - The Sympathetic Nervous System in Chronic Heart Failure and Its Response to Vasodilator Therapy. - Regulation of Renal Hemodynamics in Congestive Heart Failure. - The Renin-Angiotensin-Aldosterone System in Congestive Heart Failure. - Endogenous Catecholamines Under Chronic Vasodilator Treatment. - Effects of Hydralazine and Isosorbide Dinitrate on Vasoconstrictor Mechanisms in Patients with Heart Failure. - II. Pharmacology. - Cellular Mechanism of Action of Directly Acting Vasodilator Drugs. - Pharmacokinetics of Nitrates. - Isosorbide Dinitrate: Pharmacokinetics After Intravenous Administration. - Prazosin and ? -Blocking Agents. - III. Clinical Experience. - Promises and Disappointments of Vasodilator Treatment of Chronic Heart Failure. - Nitrates in Chronic Heart Failure. - The Long-Term Effects of Dihydralazine and Hydralazine on Intractable Cardiac Failure. - The Use for Hydralazine in Chronic Cardiac Failure: Results and Unanswered Questions. - Prazosin Therapy in Severe Chronic Congestive Heart Failure. - Early Experience with Captopril in Congestive Heart Failure. - Acute Effect of Nifedipine on Left Ventricular Performance at Rest and During Exercise in Patients with Left Ventricular Dysfunction. - Treatment of Congestive Heart Failure with Dipyridamole. - Therapeutic Agents with Combined Inotropic and Vasodilating Properties. - Hemodynamic Effects of Combined Inotropic and Vasodilator Drugs in Severe Congestive Heart Failure: Hydralazine and Prenalterol. - AR-L 115 BS, a Substance with Inotropic and Vasodilating Effects. - Efficacy of AR-L 115 BS on Hemodynamics, Contractility, andMyocardial Oxygen Consumption in Man. - Treatment of Cardiac Failure with AR-L 115 BS. - IV. Conception and Planning of Future Studies. - Can Vasodilator Treatment Improve Life Expectancy and Physical Performance Heart Failure? . - Vasodilators in Chronic Heart Failure: Problems of Design and Analysis of Controlled Clinical Trials.